Paul Daruwala
2017
In 2017, Paul Daruwala earned a total compensation of $996.8K as Chief Operating Officer at Cidara Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $75,700 |
|---|---|
| Option Awards | $308,066 |
| Salary | $335,000 |
| Stock Awards | $278,000 |
| Total | $996,766 |
Daruwala received $335K in salary, accounting for 34% of the total pay in 2017.
Daruwala also received $75.7K in non-equity incentive plan, $308.1K in option awards and $278K in stock awards.
Rankings
In 2017, Paul Daruwala's compensation ranked 8,986th out of 14,666 executives tracked by ExecPay. In other words, Daruwala earned more than 38.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,986 out of 14,666 | 39th |
Division Manufacturing | 3,440 out of 5,772 | 40th |
Major group Chemicals And Allied Products | 1,175 out of 2,075 | 43rd |
Industry group Drugs | 939 out of 1,731 | 46th |
Industry Biological Products, Except Diagnostic Substances | 167 out of 313 | 47th |
Source: SEC filing on April 26, 2019.
Daruwala's colleagues
We found three more compensation records of executives who worked with Paul Daruwala at Cidara Therapeutics in 2017.